Turkish version of the Impact of Brachial Plexus Injury Questionnaire (IMBPIQ)

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This methodological study translates the IMBPIQ into Turkish and tests its validity and reliability in adults with brachial plexus birth palsy. Sixty participants? (Note: number stated in summary is 50) will complete the Turkish IMBPIQ along with the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire and the SF-36. The study assesses internal consistency, test-retest reliability, and construct validity to ensure the Turkish version reflects the same constructs as the original. Translation involves forward translation, expert review, back-translation, and semantic/cultural reconciliation, followed by a pilot test. Lead sponsor is Biruni University in Istanbul.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Being 18 years of age or older.
* Having a diagnosis of brachial plexus birth palsy.
* Having the ability to read, write, speak, and understand Turkish.
* Agreeing to participate voluntarily in the study and signing the informed consent form.

Exclusion Criteria:

* Having a neurological disease.
* Having another orthopedic problem or a history of trauma in the affected upper extremity.
* Having a severe cognitive or communication impairment that may prevent completion of the questionnaires or understanding of the study instructions.
* Having a history of systemic disease requiring an acute attack or hospitalization within the last three months.
* Being pregnant or being in the postpartum period of less than 6 months.

Where it's running

• Biruni University
  Istanbul, Istanbul, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Fahri Dogukan Bozkurt, Physiotherapist, MSc Student
• Email: fahrib@biruni.edu.tr
• Phone: +905392870087

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pain, function, and social appearance in adults after shoulder tendon transfer for obstetric brachial plexus palsy

  This study tests how adults who had a shoulder tendon transfer in childhood fare in pain, arm movement, strength, daily function, and social appearance compared with healthy peers.

  Recruiting Biruni University · Istanbul, Istanbul · NCT07655271

• Sensory integration therapy to support development in babies with birth-related brachial plexus injury

  This trial will test whether weekly sensory integration therapy helps children aged 7 to 35 months with congenital brachial plexus injury improve sensory, motor, and cognitive development.

  Recruiting Hacettepe University · Ankara · NCT07134049

• Training program for caregivers of infants with brachial plexus birth injury

  This study is testing a new training program for caregivers of infants with brachial plexus birth injury to see if it helps improve their babies' arm movement.

  Recruiting at 2 sites Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · St. Petersburg, Florida and 1 other locations · NCT06623357

• Using botulinum toxin injections to prevent shoulder deformity in babies with a specific nerve injury

  This study is testing if botulinum toxin injections can help prevent shoulder problems in babies with a specific nerve injury.

  Recruiting at 4 sites Phase 3 University Hospital, Brest · Brest and 6 other locations · NCT03198702

• Diffusion MRI to map nerve lesions in obstetric brachial plexus palsy

  This study tests diffusion MRI and tractography to better understand nerve injuries in people with obstetric brachial plexus palsy.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07767708

• Neurostimulation for chronic upper limb pain after brachial plexus injury

  This study is testing if spinal cord stimulation can help adults with chronic pain from a brachial plexus injury feel less pain over time.

  Recruiting at 2 sites Mayo Clinic · Jacksonville, Florida and 1 other locations · NCT04733599

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.